- Home
- MOGU vs EDSA Comparison
MOGU vs EDSA Comparison
Compare MOGU & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOGU | EDSA |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 12.8M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MOGU | EDSA |
|---|---|---|
| Price | $2.20 | $1.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 9.0K | ★ 50.3K |
| Earning Date | 11-21-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,462,964.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.83 | $1.28 |
| 52 Week High | $8.10 | $4.49 |
Technical Indicators
Market Signals| Indicator | MOGU | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 41.02 | 48.02 |
| Support Level | $2.04 | $1.43 |
| Resistance Level | $2.25 | $1.61 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 32.09 | 80.88 |
Price Performance
Historical ComparisonAbout MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.